Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Seegene unveils world's first commercialized '3 Ct' PCR assay
2022-04-26 20:32
Seegene's Allplex™ RV Master Assay receives Australian TGA approval, European CE-IVD mark
2022-04-06 20:08
Seegene appoints Dr. Glen Hansen as Head of Medical Affairs of U.S. subsidiary
2022-03-17 20:00
Seegene appoints Richard Creager as CEO of U.S. subsidiary to bolster U.S. business
2022-03-02 20:00
Seegene unveils new assay optimized for on-site testing in 'living with Covid-19' era
2022-02-24 20:00
Seegene Announces Q4 and Full-Year 2021 Financial Results
2022-02-17 20:00
Seegene Signs Supply Deal to Deliver 4 million COVID-19 Tests to Brazil
2022-02-10 20:00
Seegene to Launch New COVID-19 PCR Test with a Reduced Turnaround Time Optimized for Mass Testing
2022-01-19 20:00
Seegene Continues to Support Israel's Effort to Manage the Omicron Variant With Timely Delivery of Five Million Tests
2022-01-17 20:00
Seegene's Allplex™ SARS CoV-2 FluA/FluB/RSV Assay approved under Health Canada's Interim Order
2022-01-17 20:00
Seegene Unveils Blueprint for the Future of Molecular Diagnostics, Including Open Development Platform at the 40th Annual J.P. Morgan Healthcare Conference
2022-01-13 04:00
Seegene Airlifts 1.7 million COVID-19 Tests to Israel Battling the Omicron Variant by a charter plane
2021-12-29 19:00
Seegene Rapidly Introduces New PCR Test that Identifies the Omicron Variant, its Stealth Version, and all VOCs in a single tube
2021-12-09 20:18
Seegene's High Multiplex PCR Assay Capable of Detecting New Omicron Variant
2021-11-30 19:25
Seegene Announces Q3 2021 Earnings, Continuing COVID-Era Momentum
2021-11-23 16:03
Seegene Opens New Subsidiary in Bogotá, Colombia, to Advance Regional COVID-19 Testing
2021-11-15 19:00
Launch of Seegene's STARlet-AIOS: All-in-One System Fulfills Critical Need for Fully Automated, High-Throughput Real-Time PCR Testing
2021-10-27 23:40
Seegene Unveils Fully Automated Molecular Testing System at the 2021 AACC
2021-09-27 19:02
Seegene Receives CE-IVD Mark for Use of Combo Swab, a Self-Collection Device with Four COVID-19 Diagnostic Tests
2021-09-01 17:40
Seegene Q2 2021 Earnings Show 11 Percent Revenue Growth, YoY
2021-08-18 18:00
1
2
3
4
5